(Q37942364)

25 August 2017

1 reference

title

Small changes can make a big difference - microRNA regulation of cardiac hypertrophy (English)

1 reference

25 August 2017

1 reference

Monika M Gladka

1

1 reference

25 August 2017

Paula A da Costa Martins

series ordinal

2

1 reference

25 August 2017

Leon J De Windt

series ordinal

3

1 reference

25 August 2017

publication date

24 September 2011

1 reference

Journal of Molecular and Cellular Cardiology

25 August 2017

published in

1 reference

25 August 2017

volume

52

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

74-82

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

25 August 2017

1 reference

Myocardin induces cardiomyocyte hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Myocardin is sufficient and necessary for cardiac gene expression in Xenopus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

The cardiomyopathy of overload: an unnatural growth response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Left ventricular hypertrophy: a shift in paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Silencing of microRNA families by seed-targeting tiny LNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNAs: genomics, biogenesis, mechanism, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNAs: target recognition and regulatory functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Pervasive roles of microRNAs in cardiovascular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNA regulation in cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Identification of cardiovascular microRNA targetomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Dicer is essential for mouse development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNA-206: the skeletal muscle-specific myomiR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNAs and atrial fibrillation: new fundamentals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Load effects on gene expression during cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNA-133 controls cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

The etiology of Wolf-Hirschhorn syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Thioredoxin and ventricular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

A cyclin D2-Rb pathway regulates cardiac myocyte size and RNA polymerase III after biomechanical stress in adult myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Pathological roles of MAPK signaling pathways in human diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Comparison of different miR-21 inhibitor chemistries in a cardiac disease model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

miR-21: a miRaculous Socratic paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Control of cardiac myosin heavy chain gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Control of stress-dependent cardiac growth and gene expression by a microRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

MicroRNA profiling in early hypertrophic growth of the left ventricle in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

Myocardin is differentially required for the development of smooth muscle cells and cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.09.015

10.1016/J.YJMCC.2011.09.015

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference